Study S002387

The Effect of Pancreatin Added to Standard Antihyperglycemic Therapy on Metabolic Control in Patients With Type 2 Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07852988
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: DOUBLE
Status: RECRUITING
Enrollment: 100
Start: 2026-08-01
Primary completion: 2027-12-31
Lead sponsor: Silesian Centre for Heart Diseases
Conditions: Type 2 Diabetes (T2DM)
Interventions: DRUG:Pancreatin; DRUG:Placebo
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER_GRANT:BNW-1-089/N/5/K

Registered primary outcomes

Glycemic control [3 months]
Time in range [3 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.